Chlorpropamide
SIAL/PHR1284 - Pharmaceutical Secondary Standard; Certified Reference Material
Synonym: 1-(p-
CAS Number: 94-20-2
Empirical Formula (Hill Notation): C10H13ClN2O3S
Molecular Weight: 276.74
EC Number: 202-314-5
MDL Number: MFCD00079004
Linear Formula: C10H13ClN2O3S
Product Type: Chemical
agency | traceable to Ph. Eur. C1905000 |
traceable to USP 1126009 | |
application(s) | pharmaceutical (small molecule) |
CofA | current certificate can be downloaded |
format | neat |
grade | certified reference material |
pharmaceutical secondary standard | |
InChI | 1S/C10H13ClN2O3S/c1-2-7-1 |
InChI key | RKWGIWYCVPQPMF-UHFFFAOYSA |
Quality Level | 300 ![]() |
SMILES string | CCCNC(=O)NS(=O)(=O)c1ccc( |
storage temp. | 2-30°C |
technique(s) | gas chromatography (GC): suitable |
HPLC: suitable |
Analysis Note: | These secondary standards offer multi-traceability to the USP, EP (PhEur) and BP primary standards, where they are available. |
Application: | Chlorpropamide may be used as a pharmaceutical reference standard for the quantification of the analyte in pharmaceutical formulations using capillary zone elctrophoresis technique and spectrophotometric technique. |
Application: | These Secondary Standards are qualified as Certified Reference Materials. These are suitable for use in several analytical applications including but not limited to pharma release testing, pharma method development for qualitative and quantitative analyses, food and beverage quality control testing, and other calibration requirements. |
Footnote: | To see an example of a Certificate of Analysis for this material enter LRAA0019 in the slot below. This is an example certificate only and may not be the lot that you receive. |
General description: | Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards. Chlorpropamide belongs to the sulfonylurea class of drugs and is found to be clinically effective in the treatment of Diabetes mellitus (DM). Its mode of action involves the stimulation of insulin release from the β-cells of the pancreas in response to a glucose load. It helps in increasing the number of insulin receptors, thereby enhancing the effect of insulin on the liver and promotes peripheral glucose utilization. |
Other Notes: | This Certified Reference Material (CRM) is produced and certified in accordance with ISO 17034 and ISO/IEC 17025. All information regarding the use of this CRM can be found on the certificate of analysis. |
Symbol | ![]() ![]() |
Signal word | Warning |
Hazard statements | H302 - H361f - H373 |
Precautionary statements | P201 - P301 + P312 + P330 - P308 + P313 |
Hazard Codes | Xn |
Risk Statements | 20/21/22-40 |
Safety Statements | 22-36 |
RIDADR | NONH for all modes of transport |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-30°C |
UNSPSC | 41116107 |